Top compounds associated with response to LMNTD2


Feature Type Standardized
Nominal ANOVA
mRNA regorafenib CTRPv2 pan-cancer AAC -0.028 0.5
mRNA itraconazole CTRPv2 pan-cancer AAC -0.028 0.5
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.028 0.5
mRNA neratinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA NVP-231 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.024 0.5
mRNA HBX-41108 CTRPv2 pan-cancer AAC -0.03 0.5
mRNA JQ-1:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.024 0.5
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
Download CSV